World's Best Scientists 2026 revealed!
Tore Saxne

Tore Saxne

D-Index & Metrics

Medicine

D-Index
85
Citations
25120
World Ranking
14660
National Ranking
273

Tore Saxne publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Tore Saxne sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 293 publications — 15th percentile

15% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Tore Saxne D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Tore Saxne sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 85 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Tore Saxne is affiliated with Lund University in Sweden and focuses research primarily within the field of Medicine. Their work concentrates on several subfields, including Rheumatology, Epidemiology, Hematology, Pulmonary and Respiratory Medicine, and Immunology. The main topics addressed in their publications encompass Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research, Pneumonia and Respiratory Infections, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Immunodeficiency and Autoimmune Disorders, Tuberculosis Research and Epidemiology, and Blood Coagulation and Thrombosis Mechanisms.

Throughout their career, Saxne has contributed to various scientific journals and venues, with frequent publications including:

  • Research Square (Research Square)
  • The Journal of Immunology
  • Arthritis & Rheumatology
  • Vaccine
  • BMC Rheumatology

Recent papers by Saxne highlight studies on autoimmune and infectious disease mechanisms as well as therapeutic outcomes. Key publications include:

  • "Apolipoprotein E Triggers Complement Activation in Joint Synovial Fluid of Rheumatoid Arthritis Patients by Binding C1q", 2020, The Journal of Immunology
  • "Sustained Remission in Patients With Rheumatoid Arthritis Receiving Triple Therapy Compared to Biologic Therapy: A Swedish Nationwide Register Study", 2021, Arthritis & Rheumatology
  • "Reduced risk of serious pneumococcal infections up to 10 years after a dose of pneumococcal conjugate vaccine in established arthritis", 2022, Vaccine
  • "Cardiovascular disease risk in early rheumatoid arthritis: the impact of cartilage oligomeric matrix protein (COMP) and disease activity", 2023, BMC Rheumatology
  • "Reduced Risk of Serious Pneumococcal Infection Up to 10 Years After 7-Valent Pneumococcal Conjugate Vaccine in Arthritis Patients", 2021, Research Square (Research Square)

Saxne frequently collaborates with several coauthors, including:

  • Meliha C Kapetanovic
  • Johanna Nagel
  • Chanchai Manuswin
  • Martin Englund
  • Jan-Åke Nilsson

Best Publications

  • Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum.

    Tore Saxne;Michael Palladino;Dick Heinegård;Norman Talal

  • Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis

    Lennart T H Jacobsson;Carl Turesson;Anders Gülfe;Meliha C Kapetanovic

  • Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists

    J Askling;C M Fored;Eva Baecklund;L Brandt

  • Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab.

    Klaus Bendtzen;Pierre Geborek;Morten Svenson;Lotta Larsson

  • The role of the cartilage matrix in osteoarthritis

    Dick Heinegård;Tore Saxne

  • Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden.

    Johan Askling;C. Michael Fored;Lena Brandt;Eva Baecklund

  • Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists

    J Askling;CM Fored;L Brandt;E Baecklund

  • IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.

    L.A.B. Joosten;M.M.A. Helsen;T. Saxne;F.A.J. van de Loo

  • Prognostic laboratory markers of joint damage in rheumatoid arthritis

    Elisabet Lindqvist;Kerstin Eberhardt;Klaus Bendtzen;Dick Heinegard

  • CARTILAGE OLIGOMERIC MATRIX PROTEIN: A NOVEL MARKER OF CARTILAGE TURNOVER DETECTABLE IN SYNOVIAL FLUID AND BLOOD

    Tore Saxne;Dick Heinegård

  • Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis

    L. Van Bon;L. Van Bon;A. J. Affandi;A. J. Affandi;J. Broen;J. Broen;R. B. Christmann

  • Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas

    Pierre Geborek;Anna Bladström;Carl Turesson;Anders Gulfe

  • Classification of osteoarthritis biomarkers: a proposed approach

    D. C. Bauer;D. J. Hunter;S. B. Abramson;M. Attur

  • Time‐dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists

    Johan Askling;C Michael Fored;Lena Brandt;Eva Baecklund

  • Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis

    Meliha C Kapetanovic;Tore Saxne;Anders Sjöholm;Lennart Truedsson

  • Radiographic osteoarthritis of the knee classified by the Ahlbäck and Kellgren & Lawrence systems for the tibiofemoral joint in people aged 35–54 years with chronic knee pain

    Ingemar F Petersson;Torsten Boegård;Tore Saxne;Alan J Silman

  • Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register

    Johan Askling;Eva Baecklund;F. Granath;P. Geborek

  • Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden

    Pierre Geborek;Meliha Crnkic;I F Petersson;Tore Saxne

  • Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis

    Andrew Kinloch;Karin Lundberg;Robin Wait;Natalia Wegner

  • Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?

    Johan Askling;Ronald F. van Vollenhoven;Fredrik Granath;Pauline Raaschou

Frequent Co-Authors

Dick Heinegård
Dick Heinegård Lund University
Anna M. Blom
Anna M. Blom Lund University
Lars Klareskog
Lars Klareskog Karolinska Institute
Johan Askling
Johan Askling Karolinska Institute
Martin Englund
Martin Englund Lund University
Göran Jönsson
Göran Jönsson Lund University
Anthony G. Wilson
Anthony G. Wilson University College Dublin
Elisabeth Brouwer
Elisabeth Brouwer University Medical Center Groningen
René E. M. Toes
René E. M. Toes Leiden University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a future in medicine or healthcare, there are a variety of online degree pathways to explore. Many students pursue nursing as a flexible, in-demand starting point. For current registered nurses, there are cheap rn to bsn programs that offer a cost-effective way to advance your education and open doors to leadership roles.

For those aiming higher, many universities now feature online phd programs in nursing, allowing professionals to earn a doctorate without putting their careers on hold. If you have a non-nursing bachelor’s degree but want to pivot into advanced practice, direct entry np programs for non nurses online provide a streamlined transition.

Entry requirements vary widely, so those looking for flexible options may prefer the easiest nursing programs to get into. With so many accredited online programs and alternative routes, students can find the pathway that fits their academic background and career goals.

Best Scientists Citing Tore Saxne

Trending Scientists

Recently Published Articles